: A core part of its mission is ensuring that medications remain accessible and cost-effective for patients.

Quallent Pharmaceuticals has rapidly established itself as an essential partner in the US pharmaceutical industry, delivering on its promise of making, affordable, high-quality drugs accessible. Through its strategic focus on biosimilars and essential generics, and under the umbrella of The Cigna Group, Quallent is helping to shape a future where necessary treatments are not out of reach for patients due to high costs.

Before any medication reaches a distributor, it must undergo multi-phase clinical validation. The historical evolution of major biopharmaceutical development players—such as the legacy infrastructure of (now a core component of the data-driven healthcare leader IQVIA)—highlights the industry’s dependence on centralized clinical trial networks, data management, and biometric analysis. Industrial Scale and Measurement Metrics